Glass syringes, pre-filled syringes, and syringes used for oral or topical purposes are not part of the quality control concern, the FDA said Nov. 30. Incident reports have included several syringe manufacturers based in China, so the agency is analyzing the issue that might be attributed to changes in the products’ dimension.
The FDA said it’s working with federal partners and manufacturers, adding that it “may prevent syringes made in China from entering the United States.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
